Literature DB >> 12529373

Heterodimerization of alpha 2A- and beta 1-adrenergic receptors.

Jianguo Xu1, Junqi He, Amanda M Castleberry, Srividya Balasubramanian, Anthony G Lau, Randy A Hall.   

Abstract

beta- and alpha(2)-adrenergic receptors are known to exhibit substantial cross-talk and mutual regulation in tissues where they are expressed together. We have found that the beta(1)-adrenergic receptor (beta(1)AR) and alpha(2A)-adrenergic receptor (alpha(2A)AR) heterodimerize when coexpressed in cells. Immunoprecipitation studies with differentially tagged beta(1)AR and alpha(2A)AR expressed in HEK-293 cells revealed robust co-immunoprecipitation of the two receptors. Moreover, agonist stimulation of alpha(2A)AR was found to induce substantial internalization of coexpressed beta(1)AR, providing further evidence for a physical association between the two receptors in a cellular environment. Ligand binding assays examining displacement of [(3)H]dihydroalprenolol binding to the beta(1)AR by various ligands revealed that beta(1)AR pharmacological properties were significantly altered when the receptor was coexpressed with alpha(2A)AR. Finally, beta(1)AR/alpha(2A)AR heterodimerization was found to be markedly enhanced by a beta(1)AR point mutation (N15A) that blocks N-linked glycosylation of the beta(1)AR as well as by point mutations (N10A/N14A) that block N-linked glycosylation of the alpha(2A)AR. These data reveal an interaction between beta(1)AR and alpha(2A)AR that is regulated by glycosylation and that may play a key role in cross-talk and mutual regulation between these receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529373     DOI: 10.1074/jbc.M207968200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

2.  Third-party bioluminescence resonance energy transfer indicates constitutive association of membrane proteins: application to class a g-protein-coupled receptors and g-proteins.

Authors:  Sudhakiranmayi Kuravi; Tien-Hung Lan; Arnab Barik; Nevin A Lambert
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 3.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 5.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

6.  Heterodimerization and surface localization of G protein coupled receptors.

Authors:  Kenneth P Minneman
Journal:  Biochem Pharmacol       Date:  2006-09-09       Impact factor: 5.858

7.  Regulation of alpha2AR trafficking and signaling by interacting proteins.

Authors:  Qin Wang; Lee E Limbird
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

8.  Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization.

Authors:  Fuguo Zhou; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Cell Signal       Date:  2005-06-14       Impact factor: 4.315

9.  Determination of the minimal functional ligand-binding domain of the GABAB1b receptor.

Authors:  Daniela Deriu; Martin Gassmann; Susan Firbank; Dorothee Ristig; Christina Lampert; Johannes Mosbacher; Wolfgang Froestl; Klemens Kaupmann; Bernhard Bettler; Markus G Grütter
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

10.  Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.

Authors:  Motoko Takahashi; Yoshihiro Hasegawa; Yoshitaka Ikeda; Yoshinao Wada; Michiko Tajiri; Shigeru Ariki; Rina Takamiya; Chiaki Nishitani; Motoko Araki; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.